76 results
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
14 May 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
7:55am
Total current liabilities
Operating lease liabilities, net of current portion
Deferred tax liability, net
Total liabilities
Commitments
8-K
EX-99.1
PYXS
Pyxis Oncology Inc
27 Mar 24
Other Events
4:09pm
and other current assets
Intangible assets, net
Total identifiable assets
Liabilities assumed:
Accounts payable
Accrued liabilities
Deferred tax … to the present value of the incremental after-tax cash flows attributable to the intangible asset. The fair value measurements were primarily based
8-K
EX-99.1
lue17iktkmwvjtjxm4
21 Mar 24
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
7:44am
8-K
EX-4.1
mjnuqqtcul2ol7nc9l52
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
3jjlptys
28 Feb 24
Pyxis Oncology Announces $50 Million Private Placement
7:02am
8-K
EX-10.1
3gsmana95af
28 Nov 23
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
7:22am
8-K/A
EX-99.3
h4qn79ktucqe3v 37
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-99.2
nf1r ap0e0n8qaiev
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
8-K/A
EX-99.1
mbmiirrhkbwvkz0c92
27 Oct 23
Index to Consolidated Financial Statements
4:34pm
S-8 POS
EX-4.5
sumjo3 crz
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
EX-4.3
5mcn0
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
S-8 POS
EX-4.4
af7q70e yl
23 Aug 23
Registration of securities for employees (post-effective amendment)
5:30pm
POS AM
EX-4.4
e02ayhfx 7nkd8pk
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm
POS AM
EX-4.3
hmvzfvo6nuf45xly7y
23 Aug 23
Prospectus update (post-effective amendment)
5:28pm